Polyphenol-rich sorghum brans alter colon microbiota and impact species diversity and species richness after multiple bouts of dextran sodium sulfate-induced colitis.
暂无分享,去创建一个
[1] L. Rooney,et al. Evaluation of phenolics and antioxidant activity of black sorghum hybrids , 2013 .
[2] R. Knight,et al. Impact of Ileocecal Resection and Concomitant Antibiotics on the Microbiome of the Murine Jejunum and Colon , 2013, PloS one.
[3] Alan R. Dabney,et al. Diet Complexity and Estrogen Receptor β Status Affect the Composition of the Murine Intestinal Microbiota , 2013, Applied and Environmental Microbiology.
[4] B. Bartolomé,et al. In vitro fermentation of grape seed flavan-3-ol fractions by human faecal microbiota: changes in microbial groups and phenolic metabolites. , 2013, FEMS microbiology ecology.
[5] S. Lynch,et al. Role of the microbiota in inflammatory bowel diseases. , 2012, Inflammatory bowel diseases.
[6] Sebastian Tims,et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. , 2011, Gastroenterology.
[7] G. Poli,et al. Polyphenol supplementation as a complementary medicinal approach to treating inflammatory bowel disease. , 2011, Current medicinal chemistry.
[8] I. Martínez,et al. Barcoded Pyrosequencing Reveals That Consumption of Galactooligosaccharides Results in a Highly Specific Bifidogenic Response in Humans , 2011, PloS one.
[9] V. Young,et al. Microbial ecology of the murine gut associated with the development of dextran sodium sulfate‐induced colitis , 2011, Inflammatory bowel diseases.
[10] J. Parkhill,et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota , 2011, The ISME Journal.
[11] O. Inatomi,et al. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn’s disease using terminal restriction fragment length polymorphism analysis , 2011, Journal of Gastroenterology.
[12] R. Rastmanesh. High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction. , 2011, Chemico-biological interactions.
[13] M. Clifford,et al. Bioavailability of dietary flavonoids and phenolic compounds. , 2010, Molecular aspects of medicine.
[14] E. K. Kemsley,et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota , 2010, BMC gastroenterology.
[15] Robert C. Edgar,et al. Search and clustering orders of magnitude faster than BLAST , 2010, Bioinform..
[16] Peter van Baarlen,et al. Epithelial crosstalk at the microbiota–mucosal interface , 2010, Proceedings of the National Academy of Sciences.
[17] J. Hargrove,et al. Anti-inflammatory activity of select sorghum (Sorghum bicolor) brans. , 2010, Journal of medicinal food.
[18] J. Garcia-Mazcorro,et al. Characterization of fecal microbiota in cats using universal 16S rRNA gene and group-specific primers for Lactobacillus and Bifidobacterium spp. , 2010, Veterinary microbiology.
[19] Age K. Smilde,et al. Metabolic fate of polyphenols in the human superorganism , 2010, Proceedings of the National Academy of Sciences.
[20] Frans Schuit,et al. Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway* , 2010, Inflammatory bowel diseases.
[21] William A. Walters,et al. QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.
[22] Dong-Hyun Kim,et al. Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in mice , 2010, Journal of Inflammation.
[23] S. Kumazawa,et al. Correction to Distribution and Excretion of Bilberry Anthocyanins in Mice , 2009 .
[24] R. Knight,et al. Fast UniFrac: Facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data , 2009, The ISME Journal.
[25] S. Kumazawa,et al. Distribution and excretion of bilberry anthocyanins [corrected] in mice. , 2009, Journal of agricultural and food chemistry.
[26] C. Pagliuca,et al. Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. , 2009, Molecular nutrition & food research.
[27] Harry J. Flint,et al. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. , 2009, FEMS microbiology letters.
[28] N. Salzman,et al. Prolonged Impact of Antibiotics on Intestinal Microbial Ecology and Susceptibility to Enteric Salmonella Infection , 2009, Infection and Immunity.
[29] J. Espín,et al. Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model. , 2009, Journal of agricultural and food chemistry.
[30] R. Knight,et al. The influence of sex, handedness, and washing on the diversity of hand surface bacteria , 2008, Proceedings of the National Academy of Sciences.
[31] R. Knight,et al. Evolution of Mammals and Their Gut Microbes , 2008, Science.
[32] J. Lupton,et al. Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. , 2008, Cancer research.
[33] Kristian Daly,et al. Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation. , 2007, Gastroenterology.
[34] Hauke Smidt,et al. Diversity of the human gastrointestinal tract microbiota revisited. , 2007, Environmental microbiology.
[35] N. Pace,et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.
[36] R. Xavier,et al. Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.
[37] U. Göbel,et al. Shift Towards Pro-inflammatory Intestinal Bacteria Aggravates Acute Murine Colitis via Toll-like Receptors 2 and 4 , 2007, PloS one.
[38] M. Lean,et al. The bioavailability of raspberry anthocyanins and ellagitannins in rats. , 2007, Molecular nutrition & food research.
[39] Shadi Sepehri,et al. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease , 2007, Inflammatory bowel diseases.
[40] H. Flint,et al. Understanding the effects of diet on bacterial metabolism in the large intestine , 2007, Journal of applied microbiology.
[41] L. Rooney,et al. Sorghum and millet phenols and antioxidants , 2006 .
[42] A. Ljungh,et al. Lactic acid bacteria as probiotics. , 2006, Current issues in intestinal microbiology.
[43] Rob Knight,et al. UniFrac – An online tool for comparing microbial community diversity in a phylogenetic context , 2006, BMC Bioinformatics.
[44] R. Bibiloni,et al. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. , 2006, Journal of medical microbiology.
[45] Philippe Marteau,et al. Specificities of the fecal microbiota in inflammatory bowel disease , 2006, Inflammatory bowel diseases.
[46] C. Manichanh,et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.
[47] A. Braune,et al. Xanthohumol does not affect the composition of rat intestinal microbiota. , 2005, Molecular nutrition & food research.
[48] C. Elson,et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota , 2005, Immunological reviews.
[49] H. Lochs,et al. Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease , 2005, Journal of Clinical Microbiology.
[50] G. Reid,et al. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. , 2005, FEMS microbiology ecology.
[51] M. Roberfroid,et al. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics , 2004, Nutrition Research Reviews.
[52] C. Hart,et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. , 2004, Gastroenterology.
[53] S. Itzkowitz,et al. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[54] E. Loftus. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. , 2004, Gastroenterology.
[55] J. Hampe,et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease , 2004, Gut.
[56] R. Mackie,et al. Effect of Condensed Tannins on Bacterial Diversity and Metabolic Activity in the Rat Gastrointestinal Tract , 2004, Applied and Environmental Microbiology.
[57] T. van Ree,et al. Tannins: classification and definition. , 2001, Natural product reports.
[58] R. Hammer,et al. Correlation of Cecal Microflora of HLA-B27 Transgenic Rats with Inflammatory Bowel Disease , 1998, Infection and Immunity.
[59] Z. Lu,et al. Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria. , 1998, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[60] Y. Ahn,et al. Growth‐inhibitory effects of Galla Rhois‐derived tannins on intestinal bacteria , 1998, Journal of applied microbiology.
[61] L. Butler,et al. Absorption and Distribution of 14C-Labeled Condensed Tannins and Related Sorghum Phenolics in Chickens , 1994 .
[62] T. Mitsuoka,et al. In Vivo Effects of Tea Polyphenol Intake on Human Intestinal Microflora and Metabolism. , 1992, Bioscience, biotechnology, and biochemistry.
[63] H. Blöcker,et al. Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA. , 1989, Nucleic acids research.
[64] J. Wiegel,et al. Clostridium thermobutyricum sp. nov., a Moderate Thermophile Isolated from a Cellulolytic Culture, That Produces Butyrate as the Major Product , 1989 .
[65] W. Verstraete,et al. The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals. , 2011, Fitoterapia.
[66] R. Knight,et al. Rapid denoising of pyrosequencing amplicon data: exploiting the rank-abundance distribution , 2010, Nature Methods.
[67] P. Rutgeerts,et al. T1795 Impaired Butyrate Oxidation in Ulcerative Colitis is Due to Decreased Butyrate Uptake and a Defect in the Oxidation Pathway , 2010 .
[68] E. Goulart,et al. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission , 2008 .
[69] A. Bernalier-Donadille,et al. Interaction between H2-producing and non-H2-producing cellulolytic bacteria from the human colon. , 2005, FEMS microbiology letters.